# EDGAR Filing Document

**Accession Number:** 0000744452
**File Stem:** 0001477932-26-003642
**Filing Date:** 2026-6
**Character Count:** 14384
**Document Hash:** f036d446cfa318c5fe5e80b291e4bd57
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-26-003642.hdr.sgml**: 20260604

**ACCESSION NUMBER**: 0001477932-26-003642

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260604

**DATE AS OF CHANGE**: 20260604

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNB PLUS CORP.
- **CENTRAL INDEX KEY:** 0000744452
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-TESTING LABORATORIES [8734]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 592262718
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-78682
- **FILM NUMBER:** 261063564

**BUSINESS ADDRESS:**
- **STREET 1:** 25 HEALTH SCIENCES DRIVE
- **CITY:** STONY BROOK
- **STATE:** NY
- **BUSINESS PHONE:** 631-240-8800

**MAIL ADDRESS:**
- **STREET 1:** 25 HEALTH SCIENCES DRIVE
- **CITY:** STONY BROOK
- **STATE:** NY

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** APPLIED DNA SCIENCES INC
- **DATE OF NAME CHANGE:** 20021218

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROHEALTH MEDICAL TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 20010504

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DCC ACQUISITION CORP
- **DATE OF NAME CHANGE:** 19990211
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KGPLA Holdings LLC
- **CENTRAL INDEX KEY:** 0002136086

**ORGANIZATION NAME:**
- **EIN:** 872357347
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 10830 SW 69 AVE
- **CITY:** PINECREST
- **STATE:** FL
- **ZIP:** 33156
- **BUSINESS PHONE:** 551-497-1475

**MAIL ADDRESS:**
- **STREET 1:** 10830 SW 69 AVE
- **CITY:** PINECREST
- **STATE:** FL
- **ZIP:** 33156

## Ex-99

**EXHIBIT 99.1**

<u>Joint Filing Agreement</u>

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated June 4, 2026 (including amendments thereto) with respect to the Common Stock of BNB Plus Corp. This Joint Filing Agreement shall be filed as an Exhibit to such Statement. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments to such Statement, and for the completeness and accuracy of the information concerning him or it contained in such Statement and any amendments thereto, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated: June 4, 2026<br>

---

| |
|:---|
| **KGPLA Holdings LLC** |
| */s/ Michael Komaransky* |
| Michael Komaransky |
| Manager |
| */s/ Michael Komaransky* |
| Michael Komaransky |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**BNB Plus Corp.**

*(Name of Issuer)*

**COMMON STOCK, PAR VALUE $0.001 PER SHARE**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Michael Komaransky**<br>10830 SW 69 Ave<br>Pinecrest FL 33156<br>786-778-1559

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**05/28/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**KGPLA HOLDINGS LLC** | Name of reporting person<br>**KGPLA HOLDINGS LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**BK** | Source of funds (See Instructions)<br>**BK** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1798500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1798500.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1798500.00** | Aggregate amount beneficially owned by each reporting person<br>**1798500.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.9%** | Percent of class represented by amount in Row (11)<br>**19.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** (13) Based on 7,197,228 shares of common stock issued and outstanding as of May 12, 2026, as set forth on the cover page of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 15, 2026.
 
 Includes 1,798,500 shares of Common Stock (described in 1(a) below) issuable upon conversion of Series B-1 Convertible Preferred Stock shares. As more fully described in Item 4, these shares of preferred stock are subject to a 19.99% beneficial ownership blocker and the percentage set forth on row (13) and the number of shares of Common Stock set forth on rows (8), (10) and (11) give effect to such blocker.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**KOMARANSKY MICHAEL** | Name of reporting person<br>**KOMARANSKY MICHAEL** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1798500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1798500.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1798500.00** | Aggregate amount beneficially owned by each reporting person<br>**1798500.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.9%** | Percent of class represented by amount in Row (11)<br>**19.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (13) Based on 7,197,228 shares of common stock issued and outstanding as of May 12, 2026, as set forth on the cover page of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 15, 2026.
 
 Includes 1,798,500 shares of Common Stock (described in 1(a) below) issuable upon conversion of Series B-1 Convertible Preferred Stock shares. As more fully described in Item 4, these shares of preferred stock are subject to a 19.99% beneficial ownership blocker and the percentage set forth on row (13) and the number of shares of Common Stock set forth on rows (8), (10) and (11) give effect to such blocker.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
COMMON STOCK, PAR VALUE $0.001 PER SHARE

**(b) Name of Issuer:**
BNB Plus Corp.

**(c) Address of Issuer's Principal Executive Offices:**
25 HEALTH SCIENCES DRIVE, STONY BROOK, NY, 11790

**Item 4. Purpose of Transaction**

The Reporting Persons acquired the securities for investment purposes. In the future, depending on general market and economic conditions affecting the Company and other relevant factors, the Reporting Persons may purchase additional securities of the Company or dispose of some or all of the securities they currently own from time to time in open market transactions, private transactions or otherwise. Other than as discussed above, or in connection with the Transactions, defined above in Item 3, the Reporting Persons do not currently have any plans or proposals which relate to or would result in the following described: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer, except as discussed above and except that the Reporting Persons currently contemplate acquiring additional securities of the Issuer from time to time in open market or private purchases subject to market conditions and other factors; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure, including but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above, except as discussed above.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the voting thereof, shared power to vote or to direct the voting thereof, sole power to dispose or to direct the disposition thereof, or shared power to dispose or to direct the disposition thereof, are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto.

**(b)**
The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the voting thereof, shared power to vote or to direct the voting thereof, sole power to dispose or to direct the disposition thereof, or shared power to dispose or to direct the disposition thereof, are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto. Komaransky may be deemed to have shared power with KGPLA, to vote and dispose of the securities reported in this Schedule 13D beneficially owned by KGPLA.

**(c)**
See Item 3, above.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

A copy of the Certificate of Designation of the Series B 1 Preferred Stock and Series F Common Stock Purchase Warrants, as well as the Form of Securities Purchase Agreement, Registration Rights Agreement and Guaranty Agreement described in Item 3 above are incorporated by reference herein. 
 
 Except as otherwise described in this Schedule 13D, including the Exhibits attached hereto, there are no contracts, arrangements, understandings, or relationships (legal or otherwise) among the Reporting Persons, or between any Reporting Person(s) and any third party, with respect to any securities of the Issuer, including, but not limited to, those involving the transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, put or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** KGPLA HOLDINGS LLC

**Signature:** /s/ Michael Komaransky

**Name/Title:** Manager

**Date:** 06/04/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** KOMARANSKY MICHAEL

**Signature:** /s/ Michael Komaransky

**Name/Title:** Michael Komaransky

**Date:** 06/04/2026